当前位置:首页 - 行情中心 - 惠泰医疗(688617) - 财务分析 - 现金流量表

惠泰医疗

(688617)

  

流通市值:358.91亿  总市值:358.91亿
流通股本:1.41亿   总股本:1.41亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,073,511,335.261,348,601,398.07634,320,372.212,262,516,479.49
  收到的税费返还8,785,554.335,671,213.235,671,213.237,064,970.28
  收到其他与经营活动有关的现金60,906,421.6444,101,599.5621,675,282.8951,843,236.97
  经营活动现金流入小计2,143,203,311.231,398,374,210.86661,666,868.332,321,424,686.74
  购买商品、接受劳务支付的现金390,642,573.11212,426,422.92108,809,971.49445,103,921.6
  支付给职工以及为职工支付的现金507,275,957.58363,668,530.68236,479,893.56545,483,989.29
  支付的各项税费238,367,057.51158,840,953.7162,552,788.97257,742,537.22
  支付其他与经营活动有关的现金330,858,523.57218,789,650.6287,161,626.82329,704,227.65
  经营活动现金流出小计1,467,144,111.77953,725,557.93495,004,280.841,578,034,675.76
  经营活动产生的现金流量净额676,059,199.46444,648,652.93166,662,587.49743,390,010.98
二、投资活动产生的现金流量:
  收回投资收到的现金1,731,078,765.881,210,078,765.88695,000,0002,374,900,000
  取得投资收益收到的现金4,564,016.422,811,829.371,565,764.868,006,327.64
  处置固定资产、无形资产和其他长期资产收回的现金净额70,53042,330-603,500
  收到的其他与投资活动有关的现金---101,052,777.78
  投资活动现金流入小计1,735,713,312.31,212,932,925.25696,565,764.862,484,562,605.42
  购建固定资产、无形资产和其他长期资产支付的现金233,491,613.4156,864,010.459,584,702.92650,244,936.13
  投资支付的现金2,096,000,0001,322,000,000685,000,0002,352,109,422
  支付其他与投资活动有关的现金---100,000,000
  投资活动现金流出小计2,329,491,613.41,478,864,010.4744,584,702.923,102,354,358.13
  投资活动产生的现金流量净额-593,778,301.1-265,931,085.15-48,018,938.06-617,791,752.71
三、筹资活动产生的现金流量:
  吸收投资收到的现金29,776,853.7820,873,979.28-78,533,523.52
  其中:子公司吸收少数股东投资收到的现金8,902,874.5---
  取得借款收到的现金4,000,0004,000,000--
  收到其他与筹资活动有关的现金10,000,0002,500,000-12,500,000
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计43,776,853.7827,373,979.28-91,033,523.52
  偿还债务支付的现金671,000591,000295,50071,182,000
  分配股利、利润或偿付利息支付的现金170,243,255.69170,250,745.135,415.44133,970,528.86
  支付其他与筹资活动有关的现金60,500,862.6353,224,424.282,555,980.61193,779,918.1
  筹资活动现金流出小计231,415,118.32224,066,169.412,856,896.05398,932,446.96
  筹资活动产生的现金流量净额-187,638,264.54-196,692,190.13-2,856,896.05-307,898,923.44
四、汇率变动对现金及现金等价物的影响-876,175.642,149,549.56799,616.44-13,002,729.01
五、现金及现金等价物净增加额-106,233,541.82-15,825,072.79116,586,369.82-195,303,394.18
  加:期初现金及现金等价物余额1,081,087,911.031,081,087,911.031,081,087,911.031,276,391,305.21
  期末现金及现金等价物余额974,854,369.211,065,262,838.241,197,674,280.851,081,087,911.03
补充资料:
  净利润-418,900,671.88-658,167,740.72
  资产减值准备-3,698,807.74-24,627,584.36
  固定资产和投资性房地产折旧-45,656,073.09-71,008,646.84
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-45,656,073.09-71,008,646.84
  无形资产摊销-6,951,793.65-6,374,411.13
  长期待摊费用摊销-828,670.31-3,599,514.48
  处置固定资产、无形资产和其他长期资产的损失-1,318.95--253,318.97
  固定资产报废损失-133,527.18-833,313.87
  公允价值变动损失--250,472.99--
  财务费用--1,677,906.79-6,890,960.44
  投资损失--7,896,662.55--13,170,904.11
  递延所得税--2,224,916.32--15,131,114.97
  其中:递延所得税资产减少--2,845,399.91--16,707,806.04
    递延所得税负债增加-620,483.59-1,576,691.07
  存货的减少--42,611,877.14--79,290,763.44
  经营性应收项目的减少--179,897.9--74,725,517.7
  经营性应付项目的增加-32,630,221.13-134,474,630.51
  其他--15,537,675.15-7,237,369.6
  现金的期末余额-1,065,262,838.24-1,081,087,911.03
  减:现金的期初余额-1,081,087,911.03-1,276,391,305.21
  现金及现金等价物的净增加额--15,825,072.79--195,303,394.18
公告日期2025-10-252025-08-222025-04-232025-04-23
审计意见(境内)标准无保留意见
TOP↑